2024 · pending · WO2025240505A1
Treatment of COLGALT2 Related Diseases and Disorders
Gregory McInnes
Compositions comprising oligonucleotides (siRNA or ASO) that target COLGALT2 for treating conditions associated with COLGALT2 variants.
RNA Therapeutics